AF
ORIC icon

Amalgamated Financial’s Oric Pharmaceuticals ORIC Stock Holding History

Amalgamated Financial’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$22K Buy
+4,028
New +$36.3K ﹤0.01% 2719

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Amalgamated Financial's ORIC Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Oric Pharmaceuticals (ORIC) in Q1 2022: 4,028 shares worth $22K. The stake represents ﹤0.01% of the portfolio and ranks #2719 among its holdings.

101 funds tracked by Wall St. Rank hold ORIC as of Q1 2022.

  • Amalgamated Financial held 4,028 shares of Oric Pharmaceuticals worth $22K as of Q1 2022.
  • Oric Pharmaceuticals was a new Amalgamated Financial position in Q1 2022.
  • Oric Pharmaceuticals made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2719 holding.
  • 101 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.